Duration and Nature of Long-Term Immunosuppression After Neurosurgical Procedure

Duration and Nature of Long-Term Immunosuppression After Neurosurgical Procedure
Enrolling By Invitation
18 years - 99 years
All
Phase N/A
60 participants needed
1 Location

Brief description of study

Patients greater than 18 years of age undergoing a neurosurgical procedure at Penn Medicine will be approached for enrollment. Currently, this study is open only at the HUP and Penn Presbyterian Medical Center locations.

Current research suggests that severe bodily stress caused by surgery may impair the immune system's ability to coordinate activation and suppression of the immune response. Neurological injury following neurotrauma, aneurysmal subarachnoid hemorrhage, and invasive neurosurgery have all been suggested as triggers of abnormal immune activation and loss of coordination. This research aims to investigate and characterize abberations in immune function after primary neurosurgical procedures. Study findings may increase general knowledge about the effects of neurosurgical procedures on the immune system, and therefore can potentially affect future medical education and clinical practice.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: neurosurgery,immune
  • Age: 18 years - 99 years
  • Gender: All


Updated on 04 Aug 2024. Study ID: 844325
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research